https://sudonull.com/oncolytics-biotech-immunotherapy-for-pancreatic-cancer-asco-2026
Oncolytics Biotech data at ASCO 2026: pelareorep virus activates T cells against mutant KRAS in pancreatic cancer. Learn about the breakthrough in treating 'cold' tumors.